This network funds pilot studies to expedite collaboration between the two groups, conduct model organism - based functional
studies of disease gene variants, and develop new therapeutic strategies using model organisms.
Coriell houses the world's largest biorepository of cell cultures and offers medical researchers from around the world access to these patient cell lines for
study of disease genes, use in screening -LSB-...]
Not exact matches
In the
study, whole - exome sequencing and a targeted analysis
of 90
genes implicated in heart
disease were applied to 419 unrelated SIDS cases.
As part
of the
study, researchers found that mice engineered to develop symptoms
of human inflammatory
disease, and which also lacked the ATG16L1
gene, developed gut damage.
Findings from a
study into Crohn's
disease, led by William G. Kerr, Ph.D.,
of SUNY Upstate Medical University, and his collaborators at the Erasmus Medical Center in the Netherlands, provide the first evidence that patients with debilitating inflammatory bowel
disease lack sufficient quantities
of a protein that comes from the SHIP1
gene.
McCallion's strategy to make sense
of all this data looks at the active
genes in cells affected by a
disease, groups
of genes that interact with one another, their vulnerability to mutation and information from past scientific
studies to filter more than a thousand
gene candidates for
disease risk down to just a handful within any one implicated region.
Annabelle Rodriguez
studies gene mutations that can lead to increased risk
of heart
disease, even in people with high HDL levels.
«I think it awakens the possibility
of gene therapy for neuropsychiatric
diseases,» says Husseini Manji, a senior investigator at Johnson & Johnson Pharmaceutical Research & Development in Titusville, N.J., who was not involved in the
study.
According to
studies, approximately one out
of every 40 individuals in the United States is a carrier
of the
gene responsible for spinal muscular atrophy (SMA), a neurodegenerative
disease that causes muscles to weaken over time.
The researchers analyzed the characteristics
of 178 patients with this
disease drawn from a
study of 2,995 melanoma patients enrolled in The
Genes, Environment, and Melanoma
study.
Scientists have shifted from
studying single molecules to investigating large complexes
of interacting biological macromolecules involved in processes such as metabolic pathways,
gene expression, and development
of disease.
«The state
of the art right now is targeting two or three
genes simultaneously and then looking at the effects, but we think that perhaps the
gene sets that need to be modulated to address some
of these
diseases are actually broader than that,» says Lu, who is the senior author
of the
study.
«
Gene sequencing
study reveals unusual mutations in endometriosis: Findings advance search for new ways to classify aggressive forms
of the
disease.»
Predisposition to vascular
disease was my focus here, using genetic epidemiological
studies to identify novel polymorphisms in a range
of candidate
genes.
«Or we could use it to
study the
gene networks in
diseases and get a better understanding
of how those
diseases work.»
According to recent
studies, approximately one out
of every 40 individuals in the United States is a carrier
of the
gene responsible for spinal muscular atrophy (SMA), a neurodegenerative
disease that causes muscles to weaken over time.
The search for the
gene began in Finland, whose isolated population has often been
studied for its elevated rate
of rare genetic
diseases.
Based on their results, Gigi Ebenezer, M.B.B.S., M.D., assistant professor
of neurology and the first author on the
study, reported that protein clumps were detected in 70 percent
of cases and 20 percent
of patients who carried
disease - causing
genes but hadn't yet developed symptoms.
Studying these rare
diseases «can open a new way to understand the imprinting phenomenon, to see how, in the beginning
of the development
of the embryo, the embryo answers to stimuli» that regulate how its
genes behave, says Giovanni Battista Ferrero, a pediatrician at the University
of Turin in Italy.
Meanwhile, the
gene - rich X is the most intensely
studied of the 23 chromosomes, largely because
of its role in rendering men vulnerable to an estimated 300 genetic
diseases and disorders associated with those mutations — from color blindness to muscular dystrophy to more than 200 brain disorders.
Reviewing thousands
of genome wide associate
studies (GWAS) to identify genetic variants in single nucleotide polymorphisms (SNPs), investigators at Dartmouth's Norris Cotton Cancer Center found that some alleles (one
of a pair
of genes located on a specific chromosome) are more frequently risk - associated with
disease than protective.
Specifically, the
study authors were able re-create lupus
disease processes, including the formation
of antibodies to DNA and kidney inflammation, by engineering mice that lacked the
gene for DNASE1L3.
In genetic
studies conducted by
gene researchers at the University
of Helsinki, the
gene defect causing the
disease was found in the COL7A1
gene.
«
Gene sequencing has opened a huge door to how complex these communities are,» says Patrick Seed, a Duke pediatrician specializing in infectious
disease, who with biologist Rob Jackson is a lead investigator
of the premature infant
study.
The population
study findings, including those from the JACC
study, suggest that even the partial inactivation
of ANGPTL3 — carriers typically have one mutant copy
of the
gene and one working copy — may be powerfully protective against coronary artery
disease, which has long been one
of the leading causes
of death in developed countries.
«From other
studies ***** we know that epigenetic modifications
of the DPP4
gene, which are associated with an increased production
of the enzyme, have a negative impact on the liver metabolism already in young mice, long before fatty liver
disease emerges,» says Baumeier.
Because environmental exposures have not had time to impact IBD progression in children, researchers have a clearer genetic picture
of the
disease allowing them to pick out additional
genes overlooked in adult research, says senior
study author Hakon Hakonarson, director
of the Center for Applied Genomics at The Children's Hospital
of Philadelphia.
The
study makes progress toward using
gene editing to prevent genetic
diseases, but there's still has a long way to go before clinical testing can begin, says Janet Rossant, a developmental biologist at the Hospital for Sick Children and the University
of Toronto.
Inhibiting NF - ƘB in microglia in mice slowed
disease progression by 47 percent, says Brian Kaspar, MD, a principal investigator in the Center for
Gene Therapy at Nationwide Children's and senior author
of the new
study.
«With more than 1.7 million people dying globally from TB each year and the rise
of strains that are resistant to drug treatment, we need a better way to prevent this
disease,» said the
study's principal investigator Louis Picker, M.D., who is the associate director
of the OHSU Vaccine and
Gene Therapy Institute and a professor
of pathology, molecular microbiology, and immunology in the OHSU School
of Medicine.
One
study, known as DIAN TU, will administer experimental drugs to more than 160 people in the U.S., the U.K., and Australia who have one
of three mutant
genes that cause an early - onset version
of the
disease.
Among 10,503 adults participating in a heart
disease study in Pakistan, 1,843 people have at least one
gene of which both copies have been knocked out, researchers report online April 12 in Nature.
In this
study, a team led by Panos N. Papapanou, DDS, PhD, professor and chair
of oral, diagnostic and rehabilitation sciences at the College
of Dental Medicine at CUMC, «reverse - engineered» the
gene expression data to build a map
of the genetic interactions that lead to periodontitis and identify individual
genes that appear to have the most influence on the
disease.
The celiac
study followed 6,403 newborn children with either
of two high - risk
gene groups called HLA that are important for immune function — HLA - DR3 - DQ2 or HLA - DR4 - DQ8 — to see who would develop celiac
disease or CDA.
A
study led by researchers at Boston University School
of Medicine (BUSM) provides novel insight into the impact that
genes may have on Huntington's
disease (HD).
In a
study of mice, they found that they could correct the mutated
gene that causes a rare liver disorder, in 6 percent
of liver cells — enough to cure the mice
of the
disease, known as tyrosinemia.
The researchers conducted their
studies in mice because patients with mutations in the STIM1
gene and that
of the channel it activates, ORAI1, are extremely rare and often too sick to
study due to chronic infections and lymphoproliferative
disease.
Once they found that the OTULIN
gene was abnormal in the sick children, they
studied the immune pathway in order to understand the mechanisms
of disease and to improve treatment
of these patients.
«This is the first
study to show the actual cell behaviors caused by mutations in
genes causally linked to polycystic kidney
disease, an important new step in the path towards treatment,» said Dr. Robert L. Bacallao, associate professor
of medicine at the IU School
of Medicine in Indianapolis.
By
studying how these
genes cause defects in fly and mouse models, we can improve our insights into the mechanisms related to human
disease,» said corresponding author and Dr. Hugo J. Bellen, professor
of neuroscience and molecular and human genetics at Baylor College
of Medicine and an investigator at the Howard Hughes Medical Institute.
And large, genome - wide
studies searching for genetic underpinnings for more common
diseases, such as lung cancer or autism, have pointed to the nether regions
of the genome between the protein - producing
genes — areas that were often thought to contain «junk» DNA that was not part
of the pantheon
of known
genes.
In another
study, James Musser at the National Institute
of Allergy and Infectious
Disease showed different strains
of staph could steal
genes and transform themselves simultaneously in different places around the world.
«Our aim now is to
study the role
of these new
gene switches in
disease models.»
Willette and Webb say they wanted to take a more holistic approach with this
study to better understand how this
gene affects the course
of the
disease and certain outcomes such as motor skills and anxiety.
Now a
study has found that the
gene mutation's toxic effects require higher than normal levels
of a protein called suPAR to trigger the onset and progression
of the
disease.
«We report here a
gene therapy dose - finding
study in a large animal model
of a severe muscle
disease where a single treatment resulted in dramatic rescue,» said Childers.
The new
study focused on 40 cognitively healthy older adults between the ages
of 65 and 75 who are carriers
of a
gene variant (APOE e4) that is known to contribute to the risk
of developing late - onset Alzheimer's
disease.
This essentially gives us «barcodes»
of specific
gene loci, which we can use to help untangle the complex genetics
of complex
diseases,» said Andrey Rzhetsky, PhD, professor
of genetic medicine and human genetics at the University
of Chicago, who led the
study.
The new
study — published October 18, 2016 in the journal Molecular Psychiatry — combined genetic analysis
of more than 9,000 human psychiatric patients with brain imaging, electrophysiology, and pharmacological experiments in mutant mice to suggest that mutations in the
gene DIXDC1 may act as a general risk factor for psychiatric
disease by interfering with the way the brain regulates connections between neurons.
A follow - up
study of 96 other patients with Alzheimer's
disease confirmed that this HLA variant is associated with earlier onset
of Alzheimer's, although Payami cautions that another
gene very close to HLA - A2, and not HLA - A2 itself, could be at fault.